Skip to main content
Livermore
Livermore
ZHEN

Enanta Pharmaceuticals Inc

ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001177648

No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Enanta Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ENTA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1491181+33
Shares19.4M6418.8M−602.6K (−3.1%)
Value$1.10B$3.00K$1.40B+$302.1M (+27.4%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ENTA in Q4 2021
InstitutionSharesValue% of portfolio
Darwin Global Management, Ltd.166,190$12.4M1.90%
Candriam Luxembourg S.C.A.161,358$12.1M0.08%
Paradigm Biocapital Advisors LP75,507$5.65M1.61%
Hillsdale Investment Management Inc.53,950$4.04M0.27%
Arrowstreet Capital, Limited Partnership41,642$3.11M0.00%
EAM Investors, LLC30,839$2.31M0.38%
Walleye Capital LLC29,200$2.18M0.07%
Putnam Investments LLC28,736$2.15M0.00%
Allianz Asset Management GmbH21,665$1.62M0.00%
EAM Global Investors LLC20,824$1.56M0.28%
Yousif Capital Management, LLC16,032$1.20M0.01%
Allspring Global Investments Holdings, LLC14,895$1.11M0.00%
Skandinaviska Enskilda Banken AB (publ)14,141$1.05M0.01%
PointState Capital LP13,500$1.01M0.03%
Ergoteles LLC11,148$834.0K0.03%
Marshall Wace, LLP9,670$723.0K0.00%
Toronto Dominion Bank9,305$696.0K0.00%
Qube Research & Technologies Ltd8,479$634.0K0.00%
Victory Capital Management Inc7,457$558.0K0.00%
Dynamic Technology Lab Private Ltd6,190$463.0K0.05%
Schonfeld Strategic Advisors LLC5,700$426.0K0.00%
ExodusPoint Capital Management, LP5,568$416.0K0.01%
Quantbot Technologies LP5,117$382.0K0.03%
Parallax Volatility Advisers, L.P.5,049$378.0K0.00%
Everence Capital Management Inc4,260$319.0K0.02%
Quent Capital, LLC4,110$307.0K0.06%
Janus Henderson Group PLC3,684$276.0K0.00%
Campbell & CO Investment Adviser LLC3,600$269.0K0.09%
Teacher Retirement System of Texas3,587$268.0K0.00%
Jane Street Group, LLC3,157$236.0K0.00%
Boston Family Office LLC2,850$213.0K0.01%
Franklin Resources Inc2,761$206.0K0.00%
Quantamental Technologies LLC2,724$204.0K0.10%
Simplex Trading, LLC2,428$181.0K0.01%
Point72 Hong Kong Ltd1,529$114.0K0.01%
C M Bidwell & Associates Ltd1,143$85.0K0.05%
Robeco Institutional Asset Management B.V.861$64.0K0.00%
Signet Financial Management, LLC751$56.0K0.01%
Hanseatic Management Services Inc100$7.00K0.01%
Sageworth Trust Co of South Dakota64$5.00K0.01%
EverSource Wealth Advisors, LLC38$3.00K0.00%
Massmutual Trust Co FSB8$1.00K0.00%
CWM, LLC7$1.00K0.00%
Lenox Wealth Advisors, LLC12$1.00K0.00%
Covestor Ltd6$00.00%

Sold out (12)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ENTA in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
International Biotechnology Trust PLC40,000$2.26M
Hudson Bay Capital Management LP25,000$1.42M
Winton Group Ltd15,489$880.0K
PDT Partners, LLC12,954$736.0K
M&G Investment Management Ltd9,106$519.0K
Guggenheim Capital LLC7,692$437.0K
South Dakota Investment Council1,536$87.0K
Lazard Asset Management LLC1,145$65.0K
Penserra Capital Management LLC460$26.0K
Meeder Asset Management Inc106$6.00K
Harbour Investments, Inc.3$0
Meridian Wealth Partners, LLC3$0

Not filed for Q4 2021 yet (1)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ENTA in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Berman Capital Advisors, LLC64$3.00K